N2:CMPNY
N2:DEMENT
N2:HEA
N2:MEDCON
N2:MEDREG
N2:MRCH
N2:MRCH1
N2:NAMER
N2:PHMR
N2:PUBL
N2:SCI
N2:US
Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...